Allie H Grossmann

9PUBLICATIONS
58CO-AUTHORS
Predictive and prognostic markersMolecular targetsTumour immunologyGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 08, 2026
Novel Pattern of Nuclear Staining With ROS1 Immunohistochemistry: A Case Report.

|Apr 28, 2026
Rapid activation of ARF6 after RAF inhibition augments BRAFV600E and promotes therapy resistance.

|Sep 05, 2025
Rapid activation of ARF6 after RAF inhibition augments BRAFV600E and promotes therapy resistance.

Allie Grossmann, Junhua Wang, Yinshen Wee

|Aug 04, 2024
Tumour-intrinsic endomembrane trafficking by ARF6 shapes an immunosuppressive microenvironment that drives melanomagenesis and response to checkpoint blockade therapy.

Yinshen Wee, Junhua Wang, Emily C Wilson

|Jul 01, 2024
Receptor tyrosine kinase inhibition leads to regression of acral melanoma by targeting the tumor microenvironment.

Eric A Smith, Rachel L Belote, Nelly M Cruz

|Sep 16, 2022
Transposon Mutagenesis Reveals RBMS3 Silencing as a Promoter of Malignant Progression of BRAFV600E-Driven Lung Tumorigenesis.

Aria Vaishnavi, Joseph Juan, Maebh Jacob

Pageof 2

Frequent Collaborators

4 joint publications

Michael Davies

3 joint publications

Robert L Judson-Torres

3 joint publications

Eric Smith

3 joint publications

Joshua Tay